アルコール使用障害（AUD）の薬物療法の世界市場に関する洞察、2030年までの予測

当レポートは、アルコール使用障害（AUD）の薬物療法 (Medications for Alcohol Use Disorder (AUD)) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 レポート概要

• 調査範囲
• 市場分析：タイプ別
  • 世界のアルコール使用障害（AUD）の薬物療法の市場規模成長率：タイプ別: 2019 VS 2023 VS 2030
  • Naltrexone
  • Acamprosate
  • Disulfiram
  • Other
• 市場：用途別
  • 世界のアルコール使用障害（AUD）の薬物療法の市場シェア：用途別: 2019 VS 2023 VS 2030
  • Hospital
  • Rehabilitation Institutions
  • Others
• 前提条件と制限
• 調査目的
• 対象期間

第2章 世界の市場成長トレンド

• 世界のアルコール使用障害（AUD）の薬物療法の市場展望 (2019-2030)
• 世界のアルコール使用障害（AUD）の薬物療法の市場成長トレンド：地域別
  • 世界のアルコール使用障害（AUD）の薬物療法 市場規模：地域別: 2019 VS 2023 VS 2030
  • アルコール使用障害（AUD）の薬物療法の市場規模実績：地域別 (2019-2024)
  • アルコール使用障害（AUD）の薬物療法の市場規模予測：地域別 (2025-2030)
• アルコール使用障害（AUD）の薬物療法 市場動向
  • アルコール使用障害（AUD）の薬物療法 業界動向
  • アルコール使用障害（AUD）の薬物療法 市場の促進要因
  • アルコール使用障害（AUD）の薬物療法 市場の課題
  • アルコール使用障害（AUD）の薬物療法 市場の抑制要因

第3章 競合情勢：主要企業別

• 世界規模の売上高 アルコール使用障害（AUD）の薬物療法 ：競合別
  • 世界のアルコール使用障害（AUD）の薬物療法の収益：企業別 (2019-2024)
  • 世界のアルコール使用障害（AUD）の薬物療法の収益シェア：企業別 (2019-2024)
• 世界のアルコール使用障害（AUD）の薬物療法の市場シェア：企業タイプ別 (Tier 1, Tier 2, and Tier 3)
• 世界の主要企業 アルコール使用障害（AUD）の薬物療法, 売上高ランキング, 2022 VS 2023 VS 2024
• 世界のアルコール使用障害（AUD）の薬物療法 市場集中度
  • 世界のアルコール使用障害（AUD）の薬物療法 市場集中度 (CR5 and HHI)
  • 世界の上位10・上位5企業： アルコール使用障害（AUD）の薬物療法の収益 2023
• 世界の主要企業 アルコール使用障害（AUD）の薬物療法 本社 および提供地域
• 世界の主要企業 アルコール使用障害（AUD）の薬物療法, 製品およびアプリケーション
• 世界の主要企業 アルコール使用障害（AUD）の薬物療法, 業界参入時期
• M&A, 拡張計画

第4章 アルコール使用障害（AUD）の薬物療法 内訳データ：タイプ別

• 世界のアルコール使用障害（AUD）の薬物療法の市場規模実績：タイプ別 (2019-2024)
• 世界のアルコール使用障害（AUD）の薬物療法の市場規模予測：タイプ別 (2025-2030)

第5章 アルコール使用障害（AUD）の薬物療法 内訳データ：用途別

• 世界のアルコール使用障害（AUD）の薬物療法の市場規模実績：用途別 (2019-2024)
• 世界のアルコール使用障害（AUD）の薬物療法の市場規模予測：用途別 (2025-2030)

第6章 北米

• 北米のアルコール使用障害（AUD）の薬物療法 市場規模 (2019-2030)
• 北米のアルコール使用障害（AUD）の薬物療法 市場規模：タイプ別
  • 北米のアルコール使用障害（AUD）の薬物療法 市場規模：タイプ別 (2019-2024)
  • 北米のアルコール使用障害（AUD）の薬物療法 市場規模：タイプ別 (2025-2030)
  • 北米のアルコール使用障害（AUD）の薬物療法の市場シェア：タイプ別 (2019-2030)
• 北米のアルコール使用障害（AUD）の薬物療法 市場規模：用途別
  • 北米のアルコール使用障害（AUD）の薬物療法 市場規模：用途別 (2019-2024)
  • 北米のアルコール使用障害（AUD）の薬物療法 市場規模：用途別 (2025-2030)
  • 北米のアルコール使用障害（AUD）の薬物療法の市場シェア：用途別 (2019-2030)
• 北米のアルコール使用障害（AUD）の薬物療法 市場規模：国別
  • 北米のアルコール使用障害（AUD）の薬物療法 市場規模：国別: 2019 VS 2023 VS 2030
  • 北米のアルコール使用障害（AUD）の薬物療法 市場規模：国別 (2019-2024)
  • 北米のアルコール使用障害（AUD）の薬物療法 市場 シェア 国別 (2025-2030)
  • 米国
  • カナダ

第7章 欧州

• 欧州のアルコール使用障害（AUD）の薬物療法 市場規模 (2019-2030)
• 欧州のアルコール使用障害（AUD）の薬物療法 市場規模：タイプ別
  • 欧州のアルコール使用障害（AUD）の薬物療法 市場規模：タイプ別 (2019-2024)
  • 欧州のアルコール使用障害（AUD）の薬物療法 市場規模：タイプ別 (2025-2030)
  • 欧州のアルコール使用障害（AUD）の薬物療法の市場シェア：タイプ別 (2019-2030)
• 欧州のアルコール使用障害（AUD）の薬物療法 市場規模：用途別
  • 欧州のアルコール使用障害（AUD）の薬物療法 市場規模：用途別 (2019-2024)
  • 欧州のアルコール使用障害（AUD）の薬物療法 市場規模：用途別 (2025-2030)
  • 欧州のアルコール使用障害（AUD）の薬物療法の市場シェア：用途別 (2019-2030)
• 欧州のアルコール使用障害（AUD）の薬物療法 市場規模：国別
  • 欧州のアルコール使用障害（AUD）の薬物療法 市場規模：国別: 2019 VS 2023 VS 2030
  • 欧州のアルコール使用障害（AUD）の薬物療法 市場規模：国別 (2019-2024)
  • 欧州のアルコール使用障害（AUD）の薬物療法 市場規模：国別 (2025-2030)
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • ロシア
  • 北欧

第8章 中国

• 中国のアルコール使用障害（AUD）の薬物療法 市場規模 (2019-2030)
• 中国のアルコール使用障害（AUD）の薬物療法 市場規模：タイプ別
  • 中国のアルコール使用障害（AUD）の薬物療法 市場規模：タイプ別 (2019-2024)
  • 中国のアルコール使用障害（AUD）の薬物療法 市場規模：タイプ別 (2025-2030)
  • 中国のアルコール使用障害（AUD）の薬物療法の市場シェア：タイプ別 (2019-2030)
• 中国のアルコール使用障害（AUD）の薬物療法 市場規模：用途別
  • 中国のアルコール使用障害（AUD）の薬物療法 市場規模：用途別 (2019-2024)
  • 中国のアルコール使用障害（AUD）の薬物療法 市場規模：用途別 (2025-2030)
  • 中国のアルコール使用障害（AUD）の薬物療法の市場シェア：用途別 (2019-2030)

第9章 アジア（中国を除く）

• アジア地域 アルコール使用障害（AUD）の薬物療法 市場規模 (2019-2030)
• アジア地域 アルコール使用障害（AUD）の薬物療法 市場規模：タイプ別
  • アジア地域 アルコール使用障害（AUD）の薬物療法 市場規模：タイプ別 (2019-2024)
  • アジア地域 アルコール使用障害（AUD）の薬物療法 市場規模：タイプ別 (2025-2030)
  • アジア地域 アルコール使用障害（AUD）の薬物療法の市場シェア：タイプ別 (2019-2030)
• アジア地域 アルコール使用障害（AUD）の薬物療法 市場規模：用途別
  • アジア地域 アルコール使用障害（AUD）の薬物療法 市場規模：用途別 (2019-2024)
  • アジア地域 アルコール使用障害（AUD）の薬物療法 市場規模：用途別 (2025-2030)
  • アジア地域 アルコール使用障害（AUD）の薬物療法の市場シェア：用途別 (2019-2030)
• アジア地域 アルコール使用障害（AUD）の薬物療法 市場規模：地域別
  • アジア地域 アルコール使用障害（AUD）の薬物療法 市場規模：地域別: 2019 VS 2023 VS 2030
  • アジア地域 アルコール使用障害（AUD）の薬物療法 市場規模：地域別 (2019-2024)
  • アジア地域 アルコール使用障害（AUD）の薬物療法 市場規模：地域別 (2025-2030)
  • 日本
  • 韓国
  • 台湾
  • 東南アジア
  • インド
  • オーストラリア

第10章 中近東・アフリカ・中南米

• 中近東・アフリカ・中南米 アルコール使用障害（AUD）の薬物療法 市場規模 (2019-2030)
• 中近東・アフリカ・中南米 アルコール使用障害（AUD）の薬物療法 市場規模：タイプ別
  • 中近東・アフリカ・中南米 アルコール使用障害（AUD）の薬物療法 市場規模：タイプ別 (2019-2024)
  • 中近東・アフリカ・中南米 アルコール使用障害（AUD）の薬物療法 市場規模：タイプ別 (2025-2030)
  • 中近東・アフリカ・中南米 アルコール使用障害（AUD）の薬物療法の市場シェア：タイプ別 (2019-2030)
• 中近東・アフリカ・中南米 アルコール使用障害（AUD）の薬物療法 市場規模：用途別
  • 中近東・アフリカ・中南米 アルコール使用障害（AUD）の薬物療法 市場規模：用途別 (2019-2024)
  • 中近東・アフリカ・中南米 アルコール使用障害（AUD）の薬物療法 市場規模：用途別 (2025-2030)
  • 中近東・アフリカ・中南米 アルコール使用障害（AUD）の薬物療法の市場シェア：用途別 (2019-2030)
• 中近東・アフリカ・中南米 アルコール使用障害（AUD）の薬物療法 市場規模：国別
  • 中近東・アフリカ・中南米 アルコール使用障害（AUD）の薬物療法 市場規模：国別: 2019 VS 2023 VS 2030
  • 中近東・アフリカ・中南米 アルコール使用障害（AUD）の薬物療法 市場規模：国別 (2019-2024)
  • 中近東・アフリカ・中南米 アルコール使用障害（AUD）の薬物療法 市場規模：国別 (2025-2030)
  • ブラジル
  • メキシコ
  • トルコ
  • サウジアラビア
  • イスラエル
  • 湾岸協力理事会諸国

第11章 主要企業のプロファイル

• Alkermes
• Merck KGaA
• Lundbeck
• Alvogen
• Mylan
• Teva
• Sun Pharmaceutical Industries
• Zydus Pharmaceuticals
• Taj Pharmaceuticals
• TAGI Pharma Inc.
• Beijing Wellso Pharmaceutical Co
• Glenmark Pharmaceuticals
• Rusan Pharma Ltd

第12章 アナリストによる分析/結論

第13章 付録

List of Tables

Table 1. Global Medications for Alcohol Use Disorder (AUD) Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Naltrexone

Table 3. Key Players of Acamprosate

Table 4. Key Players of Disulfiram

Table 5. Key Players of Other

Table 6. Global Medications for Alcohol Use Disorder (AUD) Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Medications for Alcohol Use Disorder (AUD) Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Medications for Alcohol Use Disorder (AUD) Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global Medications for Alcohol Use Disorder (AUD) Market Share by Region (2019-2024)

Table 10. Global Medications for Alcohol Use Disorder (AUD) Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global Medications for Alcohol Use Disorder (AUD) Market Share by Region (2025-2030)

Table 12. Medications for Alcohol Use Disorder (AUD) Market Trends

Table 13. Medications for Alcohol Use Disorder (AUD) Market Drivers

Table 14. Medications for Alcohol Use Disorder (AUD) Market Challenges

Table 15. Medications for Alcohol Use Disorder (AUD) Market Restraints

Table 16. Global Medications for Alcohol Use Disorder (AUD) Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global Medications for Alcohol Use Disorder (AUD) Market Share by Players (2019-2024)

Table 18. Global Top Medications for Alcohol Use Disorder (AUD) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medications for Alcohol Use Disorder (AUD) as of 2023)

Table 19. Global Medications for Alcohol Use Disorder (AUD) Industry Ranking 2022 VS 2023

Table 20. Global 5 Largest Players Market Share by Medications for Alcohol Use Disorder (AUD) Revenue (CR5 and HHI) & (2019-2024)

Table 21. Global Key Players of Medications for Alcohol Use Disorder (AUD), Headquarters and Area Served

Table 22. Global Key Players of Medications for Alcohol Use Disorder (AUD), Product and Application

Table 23. Global Key Players of Medications for Alcohol Use Disorder (AUD), Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Medications for Alcohol Use Disorder (AUD) Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global Medications for Alcohol Use Disorder (AUD) Revenue Market Share by Type (2019-2024)

Table 27. Global Medications for Alcohol Use Disorder (AUD) Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global Medications for Alcohol Use Disorder (AUD) Revenue Market Share by Type (2025-2030)

Table 29. Global Medications for Alcohol Use Disorder (AUD) Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global Medications for Alcohol Use Disorder (AUD) Revenue Market Share by Application (2019-2024)

Table 31. Global Medications for Alcohol Use Disorder (AUD) Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global Medications for Alcohol Use Disorder (AUD) Revenue Market Share by Application (2025-2030)

Table 33. North America Medications for Alcohol Use Disorder (AUD) Market Size by Type (2019-2024) & (US$ Million)

Table 34. North America Medications for Alcohol Use Disorder (AUD) Market Size by Type (2025-2030) & (US$ Million)

Table 35. North America Medications for Alcohol Use Disorder (AUD) Market Size by Application (2019-2024) & (US$ Million)

Table 36. North America Medications for Alcohol Use Disorder (AUD) Market Size by Application (2025-2030) & (US$ Million)

Table 37. North America Medications for Alcohol Use Disorder (AUD) Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. North America Medications for Alcohol Use Disorder (AUD) Market Size by Country (2019-2024) & (US$ Million)

Table 39. North America Medications for Alcohol Use Disorder (AUD) Market Size by Country (2025-2030) & (US$ Million)

Table 40. Europe Medications for Alcohol Use Disorder (AUD) Market Size by Type (2019-2024) & (US$ Million)

Table 41. Europe Medications for Alcohol Use Disorder (AUD) Market Size by Type (2025-2030) & (US$ Million)

Table 42. Europe Medications for Alcohol Use Disorder (AUD) Market Size by Application (2019-2024) & (US$ Million)

Table 43. Europe Medications for Alcohol Use Disorder (AUD) Market Size by Application (2025-2030) & (US$ Million)

Table 44. Europe Medications for Alcohol Use Disorder (AUD) Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Europe Medications for Alcohol Use Disorder (AUD) Market Size by Country (2019-2024) & (US$ Million)

Table 46. Europe Medications for Alcohol Use Disorder (AUD) Market Size by Country (2025-2030) & (US$ Million)

Table 47. China Medications for Alcohol Use Disorder (AUD) Market Size by Type (2019-2024) & (US$ Million)

Table 48. China Medications for Alcohol Use Disorder (AUD) Market Size by Type (2025-2030) & (US$ Million)

Table 49. China Medications for Alcohol Use Disorder (AUD) Market Size by Application (2019-2024) & (US$ Million)

Table 50. China Medications for Alcohol Use Disorder (AUD) Market Size by Application (2025-2030) & (US$ Million)

Table 51. Asia Medications for Alcohol Use Disorder (AUD) Market Size by Type (2019-2024) & (US$ Million)

Table 52. Asia Medications for Alcohol Use Disorder (AUD) Market Size by Type (2025-2030) & (US$ Million)

Table 53. Asia Medications for Alcohol Use Disorder (AUD) Market Size by Application (2019-2024) & (US$ Million)

Table 54. Asia Medications for Alcohol Use Disorder (AUD) Market Size by Application (2025-2030) & (US$ Million)

Table 55. Asia Medications for Alcohol Use Disorder (AUD) Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 56. Asia Medications for Alcohol Use Disorder (AUD) Market Size by Region (2019-2024) & (US$ Million)

Table 57. Asia Medications for Alcohol Use Disorder (AUD) Market Size by Region (2025-2030) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Medications for Alcohol Use Disorder (AUD) Market Size by Type (2019-2024) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Medications for Alcohol Use Disorder (AUD) Market Size by Type (2025-2030) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Medications for Alcohol Use Disorder (AUD) Market Size by Application (2019-2024) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Medications for Alcohol Use Disorder (AUD) Market Size by Application (2025-2030) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Medications for Alcohol Use Disorder (AUD) Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 63. Middle East, Africa, and Latin America Medications for Alcohol Use Disorder (AUD) Market Size by Country (2019-2024) & (US$ Million)

Table 64. Middle East, Africa, and Latin America Medications for Alcohol Use Disorder (AUD) Market Size by Country (2025-2030) & (US$ Million)

Table 65. Alkermes Company Details

Table 66. Alkermes Business Overview

Table 67. Alkermes Medications for Alcohol Use Disorder (AUD) Product

Table 68. Alkermes Revenue in Medications for Alcohol Use Disorder (AUD) Business (2019-2024) & (US$ Million)

Table 69. Alkermes Recent Development

Table 70. Merck KGaA Company Details

Table 71. Merck KGaA Business Overview

Table 72. Merck KGaA Medications for Alcohol Use Disorder (AUD) Product

Table 73. Merck KGaA Revenue in Medications for Alcohol Use Disorder (AUD) Business (2019-2024) & (US$ Million)

Table 74. Merck KGaA Recent Development

Table 75. Lundbeck Company Details

Table 76. Lundbeck Business Overview

Table 77. Lundbeck Medications for Alcohol Use Disorder (AUD) Product

Table 78. Lundbeck Revenue in Medications for Alcohol Use Disorder (AUD) Business (2019-2024) & (US$ Million)

Table 79. Lundbeck Recent Development

Table 80. Alvogen Company Details

Table 81. Alvogen Business Overview

Table 82. Alvogen Medications for Alcohol Use Disorder (AUD) Product

Table 83. Alvogen Revenue in Medications for Alcohol Use Disorder (AUD) Business (2019-2024) & (US$ Million)

Table 84. Alvogen Recent Development

Table 85. Mylan Company Details

Table 86. Mylan Business Overview

Table 87. Mylan Medications for Alcohol Use Disorder (AUD) Product

Table 88. Mylan Revenue in Medications for Alcohol Use Disorder (AUD) Business (2019-2024) & (US$ Million)

Table 89. Mylan Recent Development

Table 90. Teva Company Details

Table 91. Teva Business Overview

Table 92. Teva Medications for Alcohol Use Disorder (AUD) Product

Table 93. Teva Revenue in Medications for Alcohol Use Disorder (AUD) Business (2019-2024) & (US$ Million)

Table 94. Teva Recent Development

Table 95. Sun Pharmaceutical Industries Company Details

Table 96. Sun Pharmaceutical Industries Business Overview

Table 97. Sun Pharmaceutical Industries Medications for Alcohol Use Disorder (AUD) Product

Table 98. Sun Pharmaceutical Industries Revenue in Medications for Alcohol Use Disorder (AUD) Business (2019-2024) & (US$ Million)

Table 99. Sun Pharmaceutical Industries Recent Development

Table 100. Zydus Pharmaceuticals Company Details

Table 101. Zydus Pharmaceuticals Business Overview

Table 102. Zydus Pharmaceuticals Medications for Alcohol Use Disorder (AUD) Product

Table 103. Zydus Pharmaceuticals Revenue in Medications for Alcohol Use Disorder (AUD) Business (2019-2024) & (US$ Million)

Table 104. Zydus Pharmaceuticals Recent Development

Table 105. Taj Pharmaceuticals Company Details

Table 106. Taj Pharmaceuticals Business Overview

Table 107. Taj Pharmaceuticals Medications for Alcohol Use Disorder (AUD) Product

Table 108. Taj Pharmaceuticals Revenue in Medications for Alcohol Use Disorder (AUD) Business (2019-2024) & (US$ Million)

Table 109. Taj Pharmaceuticals Recent Development

Table 110. TAGI Pharma Inc. Company Details

Table 111. TAGI Pharma Inc. Business Overview

Table 112. TAGI Pharma Inc. Medications for Alcohol Use Disorder (AUD) Product

Table 113. TAGI Pharma Inc. Revenue in Medications for Alcohol Use Disorder (AUD) Business (2019-2024) & (US$ Million)

Table 114. TAGI Pharma Inc. Recent Development

Table 115. Beijing Wellso Pharmaceutical Co Company Details

Table 116. Beijing Wellso Pharmaceutical Co Business Overview

Table 117. Beijing Wellso Pharmaceutical Co Medications for Alcohol Use Disorder (AUD) Product

Table 118. Beijing Wellso Pharmaceutical Co Revenue in Medications for Alcohol Use Disorder (AUD) Business (2019-2024) & (US$ Million)

Table 119. Beijing Wellso Pharmaceutical Co Recent Development

Table 120. Glenmark Pharmaceuticals Company Details

Table 121. Glenmark Pharmaceuticals Business Overview

Table 122. Glenmark Pharmaceuticals Medications for Alcohol Use Disorder (AUD) Product

Table 123. Glenmark Pharmaceuticals Revenue in Medications for Alcohol Use Disorder (AUD) Business (2019-2024) & (US$ Million)

Table 124. Glenmark Pharmaceuticals Recent Development

Table 125. Rusan Pharma Ltd Company Details

Table 126. Rusan Pharma Ltd Business Overview

Table 127. Rusan Pharma Ltd Medications for Alcohol Use Disorder (AUD) Product

Table 128. Rusan Pharma Ltd Revenue in Medications for Alcohol Use Disorder (AUD) Business (2019-2024) & (US$ Million)

Table 129. Rusan Pharma Ltd Recent Development

Table 130. Research Programs/Design for This Report

Table 131. Key Data Information from Secondary Sources

Table 132. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Medications for Alcohol Use Disorder (AUD) Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Medications for Alcohol Use Disorder (AUD) Market Share by Type: 2023 VS 2030

Figure 3. Naltrexone Features

Figure 4. Acamprosate Features

Figure 5. Disulfiram Features

Figure 6. Other Features

Figure 7. Global Medications for Alcohol Use Disorder (AUD) Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 8. Global Medications for Alcohol Use Disorder (AUD) Market Share by Application: 2023 VS 2030

Figure 9. Hospital Case Studies

Figure 10. Rehabilitation Institutions Case Studies

Figure 11. Others Case Studies

Figure 12. Medications for Alcohol Use Disorder (AUD) Report Years Considered

Figure 13. Global Medications for Alcohol Use Disorder (AUD) Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global Medications for Alcohol Use Disorder (AUD) Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Medications for Alcohol Use Disorder (AUD) Market Share by Region: 2023 VS 2030

Figure 16. Global Medications for Alcohol Use Disorder (AUD) Market Share by Players in 2023

Figure 17. Global Top Medications for Alcohol Use Disorder (AUD) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medications for Alcohol Use Disorder (AUD) as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by Medications for Alcohol Use Disorder (AUD) Revenue in 2023

Figure 19. North America Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America Medications for Alcohol Use Disorder (AUD) Market Share by Type (2019-2030)

Figure 21. North America Medications for Alcohol Use Disorder (AUD) Market Share by Application (2019-2030)

Figure 22. North America Medications for Alcohol Use Disorder (AUD) Market Share by Country (2019-2030)

Figure 23. United States Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Canada Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Europe Medications for Alcohol Use Disorder (AUD) Market Share by Type (2019-2030)

Figure 27. Europe Medications for Alcohol Use Disorder (AUD) Market Share by Application (2019-2030)

Figure 28. Europe Medications for Alcohol Use Disorder (AUD) Market Share by Country (2019-2030)

Figure 29. Germany Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. France Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. U.K. Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Italy Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Russia Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Nordic Countries Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. China Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. China Medications for Alcohol Use Disorder (AUD) Market Share by Type (2019-2030)

Figure 37. China Medications for Alcohol Use Disorder (AUD) Market Share by Application (2019-2030)

Figure 38. Asia Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Asia Medications for Alcohol Use Disorder (AUD) Market Share by Type (2019-2030)

Figure 40. Asia Medications for Alcohol Use Disorder (AUD) Market Share by Application (2019-2030)

Figure 41. Asia Medications for Alcohol Use Disorder (AUD) Market Share by Region (2019-2030)

Figure 42. Japan Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. South Korea Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. China Taiwan Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Southeast Asia Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. India Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Australia Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Middle East, Africa, and Latin America Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. Middle East, Africa, and Latin America Medications for Alcohol Use Disorder (AUD) Market Share by Type (2019-2030)

Figure 50. Middle East, Africa, and Latin America Medications for Alcohol Use Disorder (AUD) Market Share by Application (2019-2030)

Figure 51. Middle East, Africa, and Latin America Medications for Alcohol Use Disorder (AUD) Market Share by Country (2019-2030)

Figure 52. Brazil Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Mexico Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Turkey Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Saudi Arabia Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Israel Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. GCC Countries Medications for Alcohol Use Disorder (AUD) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 58. Alkermes Revenue Growth Rate in Medications for Alcohol Use Disorder (AUD) Business (2019-2024)

Figure 59. Merck KGaA Revenue Growth Rate in Medications for Alcohol Use Disorder (AUD) Business (2019-2024)

Figure 60. Lundbeck Revenue Growth Rate in Medications for Alcohol Use Disorder (AUD) Business (2019-2024)

Figure 61. Alvogen Revenue Growth Rate in Medications for Alcohol Use Disorder (AUD) Business (2019-2024)

Figure 62. Mylan Revenue Growth Rate in Medications for Alcohol Use Disorder (AUD) Business (2019-2024)

Figure 63. Teva Revenue Growth Rate in Medications for Alcohol Use Disorder (AUD) Business (2019-2024)

Figure 64. Sun Pharmaceutical Industries Revenue Growth Rate in Medications for Alcohol Use Disorder (AUD) Business (2019-2024)

Figure 65. Zydus Pharmaceuticals Revenue Growth Rate in Medications for Alcohol Use Disorder (AUD) Business (2019-2024)

Figure 66. Taj Pharmaceuticals Revenue Growth Rate in Medications for Alcohol Use Disorder (AUD) Business (2019-2024)

Figure 67. TAGI Pharma Inc. Revenue Growth Rate in Medications for Alcohol Use Disorder (AUD) Business (2019-2024)

Figure 68. Beijing Wellso Pharmaceutical Co Revenue Growth Rate in Medications for Alcohol Use Disorder (AUD) Business (2019-2024)

Figure 69. Glenmark Pharmaceuticals Revenue Growth Rate in Medications for Alcohol Use Disorder (AUD) Business (2019-2024)

Figure 70. Rusan Pharma Ltd Revenue Growth Rate in Medications for Alcohol Use Disorder (AUD) Business (2019-2024)

Figure 71. Bottom-up and Top-down Approaches for This Report

Figure 72. Data Triangulation

Figure 73. Key Executives Interviewed

This research report focuses on the Medications for Alcohol Use Disorder (AUD) Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Medications for Alcohol Use Disorder (AUD) Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
  • 1.2.2 Naltrexone
  • 1.2.3 Acamprosate
  • 1.2.4 Disulfiram
  • 1.2.5 Other
• 1.3 Market by Application
  • 1.3.1 Global Medications for Alcohol Use Disorder (AUD) Market Share by Application: 2019 VS 2023 VS 2030
  • 1.3.2 Hospital
  • 1.3.3 Rehabilitation Institutions
  • 1.3.4 Others
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Medications for Alcohol Use Disorder (AUD) Market Perspective (2019-2030)
• 2.2 Global Medications for Alcohol Use Disorder (AUD) Growth Trends by Region
  • 2.2.1 Global Medications for Alcohol Use Disorder (AUD) Market Size by Region: 2019 VS 2023 VS 2030
  • 2.2.2 Medications for Alcohol Use Disorder (AUD) Historic Market Size by Region (2019-2024)
  • 2.2.3 Medications for Alcohol Use Disorder (AUD) Forecasted Market Size by Region (2025-2030)
• 2.3 Medications for Alcohol Use Disorder (AUD) Market Dynamics
  • 2.3.1 Medications for Alcohol Use Disorder (AUD) Industry Trends
  • 2.3.2 Medications for Alcohol Use Disorder (AUD) Market Drivers
  • 2.3.3 Medications for Alcohol Use Disorder (AUD) Market Challenges
  • 2.3.4 Medications for Alcohol Use Disorder (AUD) Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Revenue Medications for Alcohol Use Disorder (AUD) by Players
  • 3.1.1 Global Medications for Alcohol Use Disorder (AUD) Revenue by Players (2019-2024)
  • 3.1.2 Global Medications for Alcohol Use Disorder (AUD) Revenue Market Share by Players (2019-2024)
• 3.2 Global Medications for Alcohol Use Disorder (AUD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.3 Global Key Players of Medications for Alcohol Use Disorder (AUD), Ranking by Revenue, 2022 VS 2023 VS 2024
• 3.4 Global Medications for Alcohol Use Disorder (AUD) Market Concentration Ratio
  • 3.4.1 Global Medications for Alcohol Use Disorder (AUD) Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Medications for Alcohol Use Disorder (AUD) Revenue in 2023
• 3.5 Global Key Players of Medications for Alcohol Use Disorder (AUD) Head office and Area Served
• 3.6 Global Key Players of Medications for Alcohol Use Disorder (AUD), Product and Application
• 3.7 Global Key Players of Medications for Alcohol Use Disorder (AUD), Date of Enter into This Industry
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Medications for Alcohol Use Disorder (AUD) Breakdown Data by Type

• 4.1 Global Medications for Alcohol Use Disorder (AUD) Historic Market Size by Type (2019-2024)
• 4.2 Global Medications for Alcohol Use Disorder (AUD) Forecasted Market Size by Type (2025-2030)

5 Medications for Alcohol Use Disorder (AUD) Breakdown Data by Application

• 5.1 Global Medications for Alcohol Use Disorder (AUD) Historic Market Size by Application (2019-2024)
• 5.2 Global Medications for Alcohol Use Disorder (AUD) Forecasted Market Size by Application (2025-2030)

6 North America

• 6.1 North America Medications for Alcohol Use Disorder (AUD) Market Size (2019-2030)
• 6.2 North America Medications for Alcohol Use Disorder (AUD) Market Size by Type
  • 6.2.1 North America Medications for Alcohol Use Disorder (AUD) Market Size by Type (2019-2024)
  • 6.2.2 North America Medications for Alcohol Use Disorder (AUD) Market Size by Type (2025-2030)
  • 6.2.3 North America Medications for Alcohol Use Disorder (AUD) Market Share by Type (2019-2030)
• 6.3 North America Medications for Alcohol Use Disorder (AUD) Market Size by Application
  • 6.3.1 North America Medications for Alcohol Use Disorder (AUD) Market Size by Application (2019-2024)
  • 6.3.2 North America Medications for Alcohol Use Disorder (AUD) Market Size by Application (2025-2030)
  • 6.3.3 North America Medications for Alcohol Use Disorder (AUD) Market Share by Application (2019-2030)
• 6.4 North America Medications for Alcohol Use Disorder (AUD) Market Size by Country
  • 6.4.1 North America Medications for Alcohol Use Disorder (AUD) Market Size by Country: 2019 VS 2023 VS 2030
  • 6.4.2 North America Medications for Alcohol Use Disorder (AUD) Market Size by Country (2019-2024)
  • 6.4.3 North America Medications for Alcohol Use Disorder (AUD) Market Share by Country (2025-2030)
  • 6.4.4 United States
  • 6.4.5 Canada

7 Europe

• 7.1 Europe Medications for Alcohol Use Disorder (AUD) Market Size (2019-2030)
• 7.2 Europe Medications for Alcohol Use Disorder (AUD) Market Size by Type
  • 7.2.1 Europe Medications for Alcohol Use Disorder (AUD) Market Size by Type (2019-2024)
  • 7.2.2 Europe Medications for Alcohol Use Disorder (AUD) Market Size by Type (2025-2030)
  • 7.2.3 Europe Medications for Alcohol Use Disorder (AUD) Market Share by Type (2019-2030)
• 7.3 Europe Medications for Alcohol Use Disorder (AUD) Market Size by Application
  • 7.3.1 Europe Medications for Alcohol Use Disorder (AUD) Market Size by Application (2019-2024)
  • 7.3.2 Europe Medications for Alcohol Use Disorder (AUD) Market Size by Application (2025-2030)
  • 7.3.3 Europe Medications for Alcohol Use Disorder (AUD) Market Share by Application (2019-2030)
• 7.4 Europe Medications for Alcohol Use Disorder (AUD) Market Size by Country
  • 7.4.1 Europe Medications for Alcohol Use Disorder (AUD) Market Size by Country: 2019 VS 2023 VS 2030
  • 7.4.2 Europe Medications for Alcohol Use Disorder (AUD) Market Size by Country (2019-2024)
  • 7.4.3 Europe Medications for Alcohol Use Disorder (AUD) Market Size by Country (2025-2030)
  • 7.4.4 Germany
  • 7.4.5 France
  • 7.4.6 U.K.
  • 7.4.7 Italy
  • 7.4.8 Russia
  • 7.4.9 Nordic Countries

8 China

• 8.1 China Medications for Alcohol Use Disorder (AUD) Market Size (2019-2030)
• 8.2 China Medications for Alcohol Use Disorder (AUD) Market Size by Type
  • 8.2.1 China Medications for Alcohol Use Disorder (AUD) Market Size by Type (2019-2024)
  • 8.2.2 China Medications for Alcohol Use Disorder (AUD) Market Size by Type (2025-2030)
  • 8.2.3 China Medications for Alcohol Use Disorder (AUD) Market Share by Type (2019-2030)
• 8.3 China Medications for Alcohol Use Disorder (AUD) Market Size by Application
  • 8.3.1 China Medications for Alcohol Use Disorder (AUD) Market Size by Application (2019-2024)
  • 8.3.2 China Medications for Alcohol Use Disorder (AUD) Market Size by Application (2025-2030)
  • 8.3.3 China Medications for Alcohol Use Disorder (AUD) Market Share by Application (2019-2030)

9 Asia (excluding China)

• 9.1 Asia Medications for Alcohol Use Disorder (AUD) Market Size (2019-2030)
• 9.2 Asia Medications for Alcohol Use Disorder (AUD) Market Size by Type
  • 9.2.1 Asia Medications for Alcohol Use Disorder (AUD) Market Size by Type (2019-2024)
  • 9.2.2 Asia Medications for Alcohol Use Disorder (AUD) Market Size by Type (2025-2030)
  • 9.2.3 Asia Medications for Alcohol Use Disorder (AUD) Market Share by Type (2019-2030)
• 9.3 Asia Medications for Alcohol Use Disorder (AUD) Market Size by Application
  • 9.3.1 Asia Medications for Alcohol Use Disorder (AUD) Market Size by Application (2019-2024)
  • 9.3.2 Asia Medications for Alcohol Use Disorder (AUD) Market Size by Application (2025-2030)
  • 9.3.3 Asia Medications for Alcohol Use Disorder (AUD) Market Share by Application (2019-2030)
• 9.4 Asia Medications for Alcohol Use Disorder (AUD) Market Size by Region
  • 9.4.1 Asia Medications for Alcohol Use Disorder (AUD) Market Size by Region: 2019 VS 2023 VS 2030
  • 9.4.2 Asia Medications for Alcohol Use Disorder (AUD) Market Size by Region (2019-2024)
  • 9.4.3 Asia Medications for Alcohol Use Disorder (AUD) Market Size by Region (2025-2030)
  • 9.4.4 Japan
  • 9.4.5 South Korea
  • 9.4.6 China Taiwan
  • 9.4.7 Southeast Asia
  • 9.4.8 India
  • 9.4.9 Australia

10 Middle East, Africa, and Latin America

• 10.1 Middle East, Africa, and Latin America Medications for Alcohol Use Disorder (AUD) Market Size (2019-2030)
• 10.2 Middle East, Africa, and Latin America Medications for Alcohol Use Disorder (AUD) Market Size by Type
  • 10.2.1 Middle East, Africa, and Latin America Medications for Alcohol Use Disorder (AUD) Market Size by Type (2019-2024)
  • 10.2.2 Middle East, Africa, and Latin America Medications for Alcohol Use Disorder (AUD) Market Size by Type (2025-2030)
  • 10.2.3 Middle East, Africa, and Latin America Medications for Alcohol Use Disorder (AUD) Market Share by Type (2019-2030)
• 10.3 Middle East, Africa, and Latin America Medications for Alcohol Use Disorder (AUD) Market Size by Application
  • 10.3.1 Middle East, Africa, and Latin America Medications for Alcohol Use Disorder (AUD) Market Size by Application (2019-2024)
  • 10.3.2 Middle East, Africa, and Latin America Medications for Alcohol Use Disorder (AUD) Market Size by Application (2025-2030)
  • 10.3.3 Middle East, Africa, and Latin America Medications for Alcohol Use Disorder (AUD) Market Share by Application (2019-2030)
• 10.4 Middle East, Africa, and Latin America Medications for Alcohol Use Disorder (AUD) Market Size by Country
  • 10.4.1 Middle East, Africa, and Latin America Medications for Alcohol Use Disorder (AUD) Market Size by Country: 2019 VS 2023 VS 2030
  • 10.4.2 Middle East, Africa, and Latin America Medications for Alcohol Use Disorder (AUD) Market Size by Country (2019-2024)
  • 10.4.3 Middle East, Africa, and Latin America Medications for Alcohol Use Disorder (AUD) Market Size by Country (2025-2030)
  • 10.4.4 Brazil
  • 10.4.5 Mexico
  • 10.4.6 Turkey
  • 10.4.7 Saudi Arabia
  • 10.4.8 Israel
  • 10.4.9 GCC Countries

11 Key Players Profiles

• 11.1 Alkermes
  • 11.1.1 Alkermes Company Details
  • 11.1.2 Alkermes Business Overview
  • 11.1.3 Alkermes Medications for Alcohol Use Disorder (AUD) Introduction
  • 11.1.4 Alkermes Revenue in Medications for Alcohol Use Disorder (AUD) Business (2019-2024)
  • 11.1.5 Alkermes Recent Development
• 11.2 Merck KGaA
  • 11.2.1 Merck KGaA Company Details
  • 11.2.2 Merck KGaA Business Overview
  • 11.2.3 Merck KGaA Medications for Alcohol Use Disorder (AUD) Introduction
  • 11.2.4 Merck KGaA Revenue in Medications for Alcohol Use Disorder (AUD) Business (2019-2024)
  • 11.2.5 Merck KGaA Recent Development
• 11.3 Lundbeck
  • 11.3.1 Lundbeck Company Details
  • 11.3.2 Lundbeck Business Overview
  • 11.3.3 Lundbeck Medications for Alcohol Use Disorder (AUD) Introduction
  • 11.3.4 Lundbeck Revenue in Medications for Alcohol Use Disorder (AUD) Business (2019-2024)
  • 11.3.5 Lundbeck Recent Development
• 11.4 Alvogen
  • 11.4.1 Alvogen Company Details
  • 11.4.2 Alvogen Business Overview
  • 11.4.3 Alvogen Medications for Alcohol Use Disorder (AUD) Introduction
  • 11.4.4 Alvogen Revenue in Medications for Alcohol Use Disorder (AUD) Business (2019-2024)
  • 11.4.5 Alvogen Recent Development
• 11.5 Mylan
  • 11.5.1 Mylan Company Details
  • 11.5.2 Mylan Business Overview
  • 11.5.3 Mylan Medications for Alcohol Use Disorder (AUD) Introduction
  • 11.5.4 Mylan Revenue in Medications for Alcohol Use Disorder (AUD) Business (2019-2024)
  • 11.5.5 Mylan Recent Development
• 11.6 Teva
  • 11.6.1 Teva Company Details
  • 11.6.2 Teva Business Overview
  • 11.6.3 Teva Medications for Alcohol Use Disorder (AUD) Introduction
  • 11.6.4 Teva Revenue in Medications for Alcohol Use Disorder (AUD) Business (2019-2024)
  • 11.6.5 Teva Recent Development
• 11.7 Sun Pharmaceutical Industries
  • 11.7.1 Sun Pharmaceutical Industries Company Details
  • 11.7.2 Sun Pharmaceutical Industries Business Overview
  • 11.7.3 Sun Pharmaceutical Industries Medications for Alcohol Use Disorder (AUD) Introduction
  • 11.7.4 Sun Pharmaceutical Industries Revenue in Medications for Alcohol Use Disorder (AUD) Business (2019-2024)
  • 11.7.5 Sun Pharmaceutical Industries Recent Development
• 11.8 Zydus Pharmaceuticals
  • 11.8.1 Zydus Pharmaceuticals Company Details
  • 11.8.2 Zydus Pharmaceuticals Business Overview
  • 11.8.3 Zydus Pharmaceuticals Medications for Alcohol Use Disorder (AUD) Introduction
  • 11.8.4 Zydus Pharmaceuticals Revenue in Medications for Alcohol Use Disorder (AUD) Business (2019-2024)
  • 11.8.5 Zydus Pharmaceuticals Recent Development
• 11.9 Taj Pharmaceuticals
  • 11.9.1 Taj Pharmaceuticals Company Details
  • 11.9.2 Taj Pharmaceuticals Business Overview
  • 11.9.3 Taj Pharmaceuticals Medications for Alcohol Use Disorder (AUD) Introduction
  • 11.9.4 Taj Pharmaceuticals Revenue in Medications for Alcohol Use Disorder (AUD) Business (2019-2024)
  • 11.9.5 Taj Pharmaceuticals Recent Development
• 11.10 TAGI Pharma Inc.
  • 11.10.1 TAGI Pharma Inc. Company Details
  • 11.10.2 TAGI Pharma Inc. Business Overview
  • 11.10.3 TAGI Pharma Inc. Medications for Alcohol Use Disorder (AUD) Introduction
  • 11.10.4 TAGI Pharma Inc. Revenue in Medications for Alcohol Use Disorder (AUD) Business (2019-2024)
  • 11.10.5 TAGI Pharma Inc. Recent Development
• 11.11 Beijing Wellso Pharmaceutical Co
  • 11.11.1 Beijing Wellso Pharmaceutical Co Company Details
  • 11.11.2 Beijing Wellso Pharmaceutical Co Business Overview
  • 11.11.3 Beijing Wellso Pharmaceutical Co Medications for Alcohol Use Disorder (AUD) Introduction
  • 11.11.4 Beijing Wellso Pharmaceutical Co Revenue in Medications for Alcohol Use Disorder (AUD) Business (2019-2024)
  • 11.11.5 Beijing Wellso Pharmaceutical Co Recent Development
• 11.12 Glenmark Pharmaceuticals
  • 11.12.1 Glenmark Pharmaceuticals Company Details
  • 11.12.2 Glenmark Pharmaceuticals Business Overview
  • 11.12.3 Glenmark Pharmaceuticals Medications for Alcohol Use Disorder (AUD) Introduction
  • 11.12.4 Glenmark Pharmaceuticals Revenue in Medications for Alcohol Use Disorder (AUD) Business (2019-2024)
  • 11.12.5 Glenmark Pharmaceuticals Recent Development
• 11.13 Rusan Pharma Ltd
  • 11.13.1 Rusan Pharma Ltd Company Details
  • 11.13.2 Rusan Pharma Ltd Business Overview
  • 11.13.3 Rusan Pharma Ltd Medications for Alcohol Use Disorder (AUD) Introduction
  • 11.13.4 Rusan Pharma Ltd Revenue in Medications for Alcohol Use Disorder (AUD) Business (2019-2024)
  • 11.13.5 Rusan Pharma Ltd Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
    • 13.1.1.1 Research Programs/Design
    • 13.1.1.2 Market Size Estimation
    • 13.1.1.3 Market Breakdown and Data Triangulation
  • 13.1.2 Data Source
    • 13.1.2.1 Secondary Sources
    • 13.1.2.2 Primary Sources
• 13.2 Author Details
• 13.3 Disclaimer